BSEInsider Trading / SAST6d ago · 29 Jul 2026, 10:11 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Jupiter Life Line Hospitals Ltd · 543980
✦ AI SummaryPledge
Jupiter Life Line Hospitals Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the creation of a pledge over certain equity shares in favour of Catalyst Trusteeship Limited.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk6/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jupiter Life Line Hospitals Ltd - 543980 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Attachments (1)
📄pdf
Download →
0503306C_2BB7_4D88_AF8F_E2C3E6549AD9_101121.pdf
View document text
CL/SAST/26-27/00735 Date: July 28, 2026
1) National Stock Exchange of India Limited
Exchange Plaza, Bandra Kurla
Complex, Bandra (East),
Mumbai – 400051.
2) BSE Limited
Floor 25, P. J. Towers,
Dalal Street, Mumbai,
Mumbai – 400001.
3) Jupiter Life Line Hospitals Limited
1004, 10th Floor, 360 Degree Business Park Maharana Pratap Chowk
LBS Marg, Mumbai City, Mulund West,
Maharashtra, India, 400080
Dear Sir / Madam,
Sub.: Disclosure under Regulation 29(2) of Securities and Exchange Board of India (Substantial
Acquisition of Shares and Takeover) Regulations 2011 in relation to creation of pledge over certain equity
shares of Jupiter Life Line Hospitals Limited
Pursuant to the disclosure required to be made under Regulation 29(2) of the SEBI (Substantial
Acquisition of Shares and Takeovers) Regulations, 2011, please find attached the disclosure in respect
of the pledged equity shares of Jupiter Life Line Hospitals Limited (“Target Company”) in favour of
Catalyst Trusteeship Limited in the capacity of Debenture Trustee for the benefit of Debenture holders.
This is for your information and records.
Sincerely,
For Catalyst Trusteeship Limited
Authorised Signatory
Name: Deesha Srikkanth
Designation: Senior Vice President
Place: Mumbai
Encl.: As above
ANNEXURE A
Format for disclosures under Regulation 29(2) of the Securities and Exchange Board of India
(Substantial Acquisition of Shares and Takeovers) Regulations, 2011
1 Name of the Target Company (TC) Jupiter Life Line Hospitals Limited
Name(s) of the acquirer and Persons Acting in Catalyst Trusteeship Limited acting as Debenture
Concert (PAC) with the acquirer Trustee on behalf of Debenture holders
Whether the acquirer belongs to
3 No
Promoter/Promoter group
Name(s) of the Stock Exchange(s) where the BSE Limited and National Stock Exchange of
shares of TC are Listed India Limited
% w.r.t. total % w.r.t. total
share/voting diluted
5 Details of the acquisition/disposal as follows Number capital share/voting
wherever capital of
applicable (*) the TC (**)
Before the acquisition under consideration,
holding of:
a) Shares carrying voting rights - - -
b) Shares in the nature of encumbrance 33,51,950 5.11 5.11
(pledge/lien/non-disposal undertaking/others)
c) Voting rights (VR) otherwise than by shares - - -
d) Warrants/convertible securities/any other - - -
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category)
e) Total (a+b+c+d) 33,51,950 5.11 5.11
Details of acquisition / sale
a) Shares carrying voting rights acquired / sold - - -
b) VRs acquired / sold otherwise than by shares - - -
c) Warrants/convertible securities/any other - - -
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category) acquired / sold
d) Shares Pledged/ encumbered/ invoked/ 1,67,59,750 25.56 25.56
released by the acquirer
e) Total (a+b+c+/-d) 1,67,59,750 25.56 25.56
After the acquisition/sale, holding of:
a) Shares carrying voting rights - - -
b) Shares encumbered with the acquirer (pledge) 2,01,11,700 30.67 30.67
c) VRs otherwise than by shares - - -
d) Warrants/convertible securities/any other
instrument that entitles the acquirer to receive
- - -
shares carrying voting rights in the TC (specify
holding in each category) after acquisition
e) Total (a+b+c+d) 2,01,11,700 30.67 30.67
Mode of acquisition / disposal / sale (e.g. open
market / off market/ public issue/ rights issue/ By way of creation of pledge over shares
preferential allotment / inter-se transfer, etc.)
Date of acquisition/ disposal / sale of shares
/VR or date of receipt of intimation of allotment June 25, 2026
of shares, whichever is applicable.
Rs. 13,11,32,044 (6,55,66,022 Equity shares
Equity share capital/total voting capital of the
having face value of Rs 2 each)
TC before the said acquisition/ disposal/ sale
Rs. 13,11,32,044 (6,55,66,022 Equity shares
Equity share capital/ total voting capital of the
having face value of Rs 2 each)
TC after the said acquisition/ disposal/ sale
Total diluted share/voting capital of the TC
Not Applicable
after the said acquisition/ disposal
Note:
(*) Total share capital/voting capital to be taken as per the latest filing done by the company to the Stock
Exchange under Clause 35 of the listing Agreement.
(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of
the outstanding convertible securities/warrants into equity shares of the TC.
Signature of the acquirer / seller / Authorised Signatory
For Catalyst Trusteeship Limited
Authorised Signatory
Name: Deesha Srikkanth
Designation: Senior Vice President
Place: Mumbai
Date: July 28, 2026